Radioactive drug seeks and attacks advanced breast cancer in first human test
Disease control
Recruiting now
This is the first time a new radioactive drug called [177Lu]Lu-ABY-271 is being tested in people. The study aims to see if it is safe and how it moves to tumors and organs in patients with advanced HER2-positive breast cancer that has spread. It will involve up to 21 participants…
Phase: PHASE1 • Sponsor: Affibody • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC